Adaptin Bio (APTN) Net Cash Flow (2024 - 2026)
Adaptin Bio (APTN) posted Net Cash Flow of -$157865.0 for Q1 2026, down 31.65% sequentially from -$119915.0 in Q4 2025, and down 106.75% YoY from $2.3 million in Q1 2025.
Adaptin Bio (APTN) Net Cash Flow (2024 - 2026) Analysis & Trends
Adaptin Bio has reported Net Cash Flow for 3 years, with the latest figure at -$157865.0 in Q1 2026.
- Quarterly Net Cash Flow fell 106.75% year-over-year to -$157865.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 187.5% YoY) and the FY2025 annual result came in at $425089.0, up 1349.28% from the prior year.
- Net Cash Flow declined to -$157865.0 in Q1 2026 per APTN's latest filing, from -$119915.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $2.3 million in Q1 2025 and troughed at -$1.0 million in Q2 2025.
- A 3-year average of $32950.6 and a median of -$81223.0 in 2024 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 767160.33% in 2025, down 5564.07% in 2025.
- Over 3 years, Net Cash Flow stood at -$81223.0 in 2024, then slumped by 47.64% to -$119915.0 in 2025, then tumbled by 31.65% to -$157865.0 in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$157865.0, -$119915.0, and -$772430.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 369,179.00 |
| Jun 30, 2026 | 369,179.00 |
| Mar 31, 2026 | -157,865.00 |
| Mar 31, 2026 | -157,865.00 |
| Dec 31, 2025 | -119,915.00 |
| Dec 31, 2025 | -119,915.00 |
| Sep 30, 2025 | -772,430.00 |
| Sep 30, 2025 | -772,430.00 |
| Jun 30, 2025 | -1.02 Mn |
| Jun 30, 2025 | -1.02 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | -81,223.00 |
| Dec 31, 2024 | -81,223.00 |
| Sep 30, 2024 | 91,532.00 |
| Sep 30, 2024 | 91,532.00 |
| Jun 30, 2024 | 18,717.00 |
| Jun 30, 2024 | 18,717.00 |
| Mar 31, 2024 | 305.00 |
| Mar 31, 2024 | 305.00 |